Satellos’ lead drug candidate SAT-3247 gets INN “forazapadin”
Satellos Bioscience announced assignment of the International Nonproprietary Name “forazapadin” for its lead drug candidate, SAT-3247.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.